Think About Juluca for HIV Patients Who Can't Tolerate Other Meds

February 2018

Juluca (jah-LOO-kah, dolutegravir/rilpivirine) will be the first two-drug combo that's a COMPLETE treatment regimen for HIV.

Most patients use THREE meds to treat HIV...often two nucleoSIDE/ nucleoTIDE reverse transcriptase inhibitors (NRTIs) PLUS another antiretroviral from a different class.

Juluca doesn't have an NRTI. It combines the integrase inhibitor, dolutegravir (Tivicay), with the NON-nucleoside reverse transcriptase inhibitor, rilpivirine (Edurant). It's a single tablet taken once daily.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Women's Health Ease Fears About Breast Cancer Risk With Hormonal Contraception
Supplements Be Aware That Biotin May Skew Lab Test Results
Cardiology Use "ABCDs" to Optimize Meds for Stable Coronary Artery Disease
Travel Medicine Save Meds for Patients at Moderate to High Risk of Altitude Sickness
Diabetes Meds Compare New GLP-1 Agonist and Flozin Options for Type 2 Diabetes
Monitoring Compare FreeStyle Libre and Other Continuous Glucose Monitors
Asthma Feel Comfortable With Long-Acting Beta-Agonists Plus Inhaled Steroids for Asthma
Psoriasis Know Key Points About Biologics for Your Patients With Psoriasis
HIV & AIDS Think About Juluca for HIV Patients Who Can't Tolerate Other Meds
Erectile Dysfunction Anticipate Interest in Generic Viagra (Sildenafil)
Practice Get Tools to Tackle This Flu Season

Think About Juluca for HIV Patients Who Can't Tolerate Other Meds

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents